HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dorn II, G. W. Articles by D'Angelo, D. D. Search for Related Content PubMed PubMed Citation Articles by Dorn II, G. W. Articles by D'Angelo, D. D. Social Bookmarking                      What's this?

Volume 272, Number 19, Issue of May 9, 1997 pp. 12399-12405
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Structural Determinants for Agonist Binding Affinity to Thromboxane/Prostaglandin Endoperoxide (TP) Receptors
ANALYSIS OF CHIMERIC RAT/HUMAN TP RECEPTORS

(Received for publication, November 26, 1996, and in revised form, February 27, 1997)

From the University of Cincinnati and the Cincinnati Veterans Administration Medical Center, Cincinnati, Ohio 45267-0542

The two most extensively characterized thromboxane/prostaglandin endoperoxide (TP) receptors, from human platelets and rat vascular smooth muscle, exhibit thromboxane agonist [15-(1,2(5Z),3-(1E,3S),4)]-7-[3-hydroxy-4-(p-iodophenoxy)-1-butenyl-7-oxabicycloheptenoic acid (I-BOP) binding affinities that differ by an order of magnitude, rat TP having the higher affinity. We utilized this difference in I-BOP affinity to identify structural determinants of TP receptor heterogeneity. No significant difference was found in the rank order of affinities for a series of thromboxane receptor ligands to bind to cloned human TP versus rat TP, indicating that these represent species homologs, not distinct TP subtypes. Structural determinants for observed differences in I-BOP binding K_d were localized by creating chimeric human/rat TP followed by mutational substitution of specific critical amino acids. Initially, seven chimeric receptors with splice sites in transmembranes 1, 2, 4, or 7 were constructed and expressed in HEK293 cells for analysis of ligand binding properties. Substitution of any part except the carboxyl tail of the human TP into the rat TP resulted in a receptor with I-BOP binding affinity intermediate between the two. Analysis of chimeras in which only the extracellular amino terminus and a portion of transmembrane 1 were switched localized the determinant of high affinity binding to the region between amino acids 3 and 40. Using this chimera, amino acids in the human portion (extracellular amino terminus and part of transmembrane 1) were replaced with analogous amino acids from rat TP to regain high affinity I-BOP binding. Only when amino acid Val³⁷ and either Val³⁶ or Ala⁴⁰ were reverted to their respective rat TP counterparts (Ala³⁶, Leu³⁷, and Gly⁴⁰, respectively) was high affinity I-BOP binding recovered. The mechanism for the increased I-BOP affinity may be the lengthening of the amino acid side chain at position 37, thus extending this group further into the putative I-BOP binding pocket, with compensatory shortening of side chains in spatially adjacent amino acids.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. T. Khasawneh, J.-S. Huang, J. W. Turek, and G. C. L. Breton Differential Mapping of the Amino Acids Mediating Agonist and Antagonist Coordination with the Human Thromboxane A2 Receptor Protein J. Biol. Chem., September 15, 2006; 281(37): 26951 - 26965. [Abstract] [Full Text] [PDF]

				L. Zhang, C. DiLizio, D. Kim, E. M. Smyth, and D. R. Manning The G12 Family of G Proteins as a Reporter of Thromboxane A2 Receptor Activity Mol. Pharmacol., April 1, 2006; 69(4): 1433 - 1440. [Abstract] [Full Text] [PDF]

				N. Qiao, D. Reynaud, P. Demin, P. V. Halushka, and C. R. Pace-Asciak The Thromboxane Receptor Antagonist PBT-3, a Hepoxilin Stable Analog, Selectively Antagonizes the TP{alpha} Isoform in Transfected COS-7 Cells J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1142 - 1147. [Abstract] [Full Text] [PDF]

				J. W. Turek, T. Halmos, N. L. Sullivan, K. Antonakis, and G. C. Le Breton Mapping of a Ligand-binding Site for the Human Thromboxane A2 Receptor Protein J. Biol. Chem., May 3, 2002; 277(19): 16791 - 16797. [Abstract] [Full Text] [PDF]

				S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid Receptors: Structures, Properties, and Functions Physiol Rev, October 1, 1999; 79(4): 1193 - 1226. [Abstract] [Full Text] [PDF]

				F. Neuschäfer-Rube, M. Oppermann, U. Möller, U. Böer, and G. P. Püschel Agonist-Induced Phosphorylation by G Protein-Coupled Receptor Kinases of the EP4 Receptor Carboxyl-Terminal Domain in an EP3/EP4 Prostaglandin E2 Receptor Hybrid Mol. Pharmacol., August 1, 1999; 56(2): 419 - 428. [Abstract] [Full Text]